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Introduction: Kasabach–Merritt syndrome is a benign condition characterized by hemangiomatosis, severely
disseminated intravascular consumption coagulopathy, and thrombocytopenia. The mortality rate increases from
12% to 30% in hemorrhagic cases. In general, the symptoms primarily manifest in the gastrointestinal tract, the
skin, and the subcutaneous tissue. There is no publication about pulmonary manifestation of angiomatosis in
combination with vascular malformation and hemoptysis. This is the first description of a Kasabach–Merritt
syndrome-like condition in the lung.
Case presentation: We present the case of a 29-year-old German woman with angiomatosis and associated pulmonary
vascular malformation in her lower left lobe with a Kasabach–Merritt syndrome like condition. It was detected
after hemoptysis. We also present our case observations and management.
Conclusion: In a case of angiomatosis with an associated pulmonary lobar vascular malformation, lobectomy
can be safely performed to prevent life-threatening bleeding.
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Angiomatosis is defined as a diffuse proliferation of
well-developed blood vessels. It is a benign condition,
continuously affecting a large segment of the body.
Formerly classified as neoplasm, it is currently defined
as vascular malformation. Approximately two-thirds of
the cases manifest in the first 2 decades of life [1].
Kasabach–Merritt Syndrome (KMS) was first described
in 1940 in a newborn male patient who presented
thrombocytopenic purpura associated with rapidly
growing capillary hemangioma [2-4]. Since then, the
term KMS has been used to describe different cases
which widely match the initial description [2]. In fact,* Correspondence: danjouma.cheufou@ruhrlandklinik.uk-essen.de
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scribing a range of vascular anomalies, leads to difficul-
ties in distinguishing “true KMS” from entities with
similar clinical presentation [2]. This, in turn, causes
confusion concerning clinical presentations and out-
comes of patients with “true KMS” [3,4].
The etiology of the KMS remains unclear. It has been
hypothesized that exposure of the subendothelial ele-
ments or abnormal endothelium within the hemangioma
results in aggregation and activation of platelets with a
secondary consumption of clotting factors [2,3,5,6].
The primary treatment includes stopping the consump-
tion coagulopathy, inducing regression of the angioma,
and resecting the hemangioma while preventing major
bleeding [7,8]. Several therapy regimes have been pro-
posed to achieve this aim. Here we present a casel. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Histological examination of the initial abdominal “tumor”. Fat
tissue with different vascular patterns ranging from small capillary and
cavernous vessels to thick-walled vessels with broadened intima
(hematoxylin and eosin staining).
Figure 3 Intraoperative view on the blood clots in the varicose veins of
the paracardial fat.
Cheufou et al. Journal of Medical Case Reports  (2015) 9:107 Page 2 of 4which was classified as KMS and treated with lower left
lobectomy.
Case presentation
A 29-year-old German woman was admitted to our
hospital with a history of hemoptysis a few days before
admission. She did not report severe coughing, emesis,
or extraordinary physical stress. She had been admitted
to another hospital 15 years ago because of significant
gastrointestinal bleeding caused by esophageal varices
of 2nd to 3rd degree. A preoperative computed tomog-
raphy (CT) scan showed an upper abdominal mass with
a potential infiltration of her liver. Furthermore, a
thrombosis of her portal vein and a partial thrombosis
of her superior mesenteric vein were detected. She dis-
played a splenomegaly with a strong lienal vein and a
paravertebral vascular plexus. She therefore underwent
laparotomy. During surgery, the lesion was diagnosed
as a hemangiomatosis of the greater omentum, extend-
ing through the hepatoduodenal ligament to the left
lobe of her liver; varicose veins of her entire stomach
wall were also detected. Because of this extension, the
lesion was classified as non-resectable. A biopsy (Figure 1)
of the tumor was performed, and an end-to-end portacaval
anastomosis was created. The biopsy was examined by
a consultant pediatric pathologist (Kiel, Germany) and
categorized as an angiomatosis. Her postoperative courseFigure 2 A chest computed tomography scan showing varicose veins of twas uneventful. Both a KMS and an eventual hereditary
telangiectasia (Osler–Weber–Rendu syndrome) were
considered. Finally, because of the clinical presentation,
the disease pattern was classified as “KMS”. Cortico-
steroid therapy was initiated for 3 months, followed by
interferon alpha (IFN -α) for an additional 3 months.
The patient survived the following 15 years without
symptoms and then returned with hemoptysis. On admis-
sion, she was clinically asymptomatic and hemodynamically
stable. Her platelet number was 139,000/μL (150,000 to
450,000/μL) and a gastroscopy revealed grade I esophageal
varices without signs of bleeding. The walls of her
esophagus, stomach, and upper small intestine were
swollen. A chest radiograph revealed a shadow on the
lower left lobe of her lung. Thereafter, a CT scan of her
thorax and abdomen was performed. We observed a
vasodilation in the lower left lobe of her lung and, in
particular, a dilation of her intrapulmonary veins (Figure 2).
The upper left lobe and her right lung were not affected.
After interdisciplinary discussion of this case, we decided to
perform a lower left lobectomy to treat hemoptysis and
prevent life-threatening bleeding. We performed an open
lower left lobectomy through a muscle-sparing antero-
axillary thoracotomy. The motivation to choose an
open procedure and not a thoracoscopic intervention
was to avoid involuntary lung manipulation and allow
control of the vulnerable dilated vessels (Figure 3). A
histopathological examination of the resected specimen
showed solitary focal vascular malformations with associ-
ated fresh and old residual hemorrhages of the neighboringhe lower lobe.
Figure 4 Histological examination of the resected lower left lung
lobe. Lung specimen with solitary vascular malformation and residual
hemorrhages in the neighboring parenchyma (hematoxylin and
eosin staining).
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Her postoperative course was uneventful. She is still
alive 2 years after the lobectomy without any clinical
symptoms of KMS.
Discussion
The presented case reflects the condition of an abdom-
inal angiomatosis with associated solitary vascular mal-
formation of the lung and KMS-like characteristics.
The most frequent sites involved with angiomatosis are
the lower extremities; followed by the chest wall, the
abdomen and upper extremities [1]. Most reported
cases of KMS displayed hemangiomas involving the
skin, in severe cases visceral sites and the retroperito-
neum [2]. In this case, the radiological findings of the
chest CT scan showed a major dilatation of the intra-
pulmonary vein originating from the lower left lobe;
therefore, we chose resection of the lower left lobe to
avoid major bleeding in the course of hemoptysis.
Numerous therapeutic approaches are available for
the treatment of KMS. Various nonsurgical therapies
have been reported for the treatment of hemangioma,
such as corticosteroids, IFN-α, vincristine, and radio-
therapy (RT); however, their use is limited due to their
side effects [9]. One of the proposed regimens is the
administration of corticosteroids. These drugs inhibit
angiogenesis, which is secondary to a variety of effects
including enhanced sensitivity of the vascular bed and
the circulation of endogenous vasoconstrictive agents [10].
Other response patterns include a partial decrease of the le-
sion size or an improvement of the bleeding disorder
with little effect on the hemangioma. In the treatment
of KMS, glucocorticosteroids yield a heterogeneousresponse, ranging from no effect to regression of the
hemangioma, and moderate to complete suppression of
coagulopathy [11].
Corticosteroids are often used in combination with
RT, IFN-α, or surgery. IFN-α inhibits angiogenesis by
suppressing overexpression of the basic fibroblast growth
factor, an angiogenic protein, in infantile hemangiomas.
Fost and Esterly [12] treated 24 pediatric patients with
hemangioma using IFN-α; they documented a complete
response in 42%, a substantial response in 16%, an
intermediate response in 26%, and no response in 16%
of the patients. However, many patients develop neuro-
logical deficits caused by IFN-α treatment, especially
when initiated at an early age. These symptoms may
disappear after the treatment is discontinued.
In the past, RT was the treatment of choice for hem-
angiomas and KMS. Approximately 85% of the cases of
hemangioma treated with RT prior to 1960 showed
complete resolution, whereas 15% showed considerable
improvement. On occasion, hemangiomas are resistant
to RT [5]. Several late effects of RT have been evaluated
and reported, such as malignancies and growth retard-
ation. These effects are closely related to the total dose
and volume of the treatment and to the employed tech-
niques. When RT is chosen, its lowest dose should be
used to decrease the occurrence of possible late effects
and secondary malignancies. However, this also causes
a decrease in the probability of successful therapy. Con-
sequently, none of the nonsurgical approaches were
chosen for the presented case because no compartment
could spatially restrict the bleeding. In a case of a lobar
manifestation of KMS, lobectomy can be safely per-
formed to prevent life-threatening bleeding.
Conclusion
In a case of angiomatosis with an associated pulmonary
lobar vascular malformation, lobectomy can be a prom-
ising option to prevent life-threatening bleeding.
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